Discover
NERV
Minerva Neurosciences, Inc.
4.48
1 x 3.85
1 x 5.00
bid
ask
+
0.11
2.52%
1 @ 04:00 PM
4.56 +0.08 (1.79%)
| Ytd | 11.44% | |
| 1y | 130.93% |
4.15
day range
4.54
1.76
52 week range
12.46
| Open | 4.31 | Prev Close | 4.37 | Low | 4.15 | High | 4.54 | Mkt Cap | 31.33M |
| Vol | 228.34K | Avg Vol | 219.32K | EPS | -1.60 | P/E | -2.80 | Forward P/E | -0.79 |
| Beta | -0.16 | Short Ratio | 0.41 | Inst. Own | 30.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.80 | 200-d Avg | 4.93 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 16.67M | ||
| Research and Development Expense | 5.25M | ||
| Selling, General and Administrative Expense | 11.42M | ||
| Operating Income | -16.67M | ||
| Net Income | -125.40M | ||
| Net Income Common Stock | -125.40M | ||
| Net Income Common Stock (USD) | -125.40M | ||
| Consolidated Income | -125.40M | ||
| Earnings per Basic Share | -2.86 | ||
| Earnings per Basic Share (USD) | -2.86 | ||
| Earnings per Diluted Share | -2.86 | ||
| Earning Before Interest & Taxes (EBIT) | -125.40M | ||
| Earning Before Interest & Taxes (USD) | -125.40M | ||
| Weighted Average Shares | 43.90M | ||
| Weighted Average Shares Diluted | 43.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 32.76M | ||
| Cash and Equivalents (USD) | 32.76M | ||
| Investments | 45.41M | ||
| Investments Current | 45.41M | ||
| Current Assets | 79.11M | ||
| Total Assets | 94.03M | ||
| Total Debt | 60.00M | ||
| Current Liabilities | 4.48M | ||
| Debt Non-Current | 60.00M | ||
| Total Liabilities | 343.08M | ||
| Accumulated Retained Earnings (Deficit) | -814.20M | ||
| Shareholders Equity | -254.01M | ||
| Shareholders Equity (USD) | -254.01M | ||
| Assets Non-Current | 14.92M | ||
| Total Debt (USD) | 60.00M | ||
| Goodwill and Intangible Assets | 14.87M | ||
| Liabilities Non-Current | 338.60M | ||
| Trade and Non-Trade Payables | 2.12M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.08M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -49.64M | ||
| Net Cash Flow from Investing | -45.29M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -45.29M | ||
| Net Cash Flow from Operations | -5.43M | ||
| Share Based Compensation | 8.71M | ||